News Tag: news

FORTE, a Colorectal Cancer Prevention Clinical Trial, accrues its first 1,000 participants

Read More

New Vice Chair named for NRG Health Disparities Committee (HDC)

Read More

FORTE Study Update – October 2023

Read More

Informed Consent Guidance Now Available

Read More

Megan Mullins, PhD, NRG Cancer Care Delivery Researcher, Examines Health Equity Issues in Latest Publication

Read More

NRG-BR009 (“OFSET”): A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression and Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score of ≤ 25

Read More

RTOG 1308 Accrual Completion: First Phase III NCTN Clinical Trial Comparing Photon Versus Proton Therapy to Meet Accrual Target

Read More

FORTE Study Update – September 2023

Read More